Goitre is prevalent at higher altitudes. This is an example of which type of association?
What is the most important factor that decides the results of a randomized controlled trial?
What is the best-known large-sample study program for coronary heart disease?
What is the definition of family size?
The burden of disease is best detected by which of the following metrics?
Among males, which of the following is the most common cancer by incidence?
The Revised National Tuberculosis Control Programme (RNTCP) was started after an evaluation of the previous program by a committee in 1992. How did it differ from the previous program?
What type of epidemiological study best establishes the temporal association of a disease?
All of the following are true about case-control studies except?
In a patient presenting with diarrhea due to Vibrio cholera, which of the following findings are typically present?
Explanation: ### Explanation **1. Why "Indirect Association" is correct:** In epidemiology, an **indirect association** occurs when a statistical relationship exists between a factor (High Altitude) and a disease (Goitre), but the factor itself is not the cause. Instead, both are linked through a **third underlying factor** (the real cause). * **The Mechanism:** High altitude does not directly cause thyroid enlargement. However, high altitudes are often associated with soil erosion and leaching, which leads to **Iodine deficiency** in the food and water supply. Since iodine deficiency is the direct cause of goitre, the link between altitude and goitre is mediated by iodine levels, making it an indirect association. **2. Why other options are incorrect:** * **Direct Association:** This occurs when a factor causes a disease without any intermediate steps (e.g., a physical trauma causing a fracture). High altitude doesn't cause goitre if iodine intake remains sufficient. * **Causal Association:** This is a broad term implying a cause-effect relationship (which can be direct or indirect). However, in the context of NEET-PG questions regarding environmental "surrogates," "Indirect" is the more specific and technically accurate epidemiological term. * **Temporal Association:** This refers to the "time" element—the cause must precede the effect. While true here, it doesn't describe the *nature* of the link between altitude and the pathology. **3. Clinical Pearls & High-Yield Facts:** * **Spurious Association:** A non-causal relationship often due to bias or chance (e.g., more TVs in a home correlating with higher cholesterol—both are actually linked to socioeconomic status). * **Multifactorial Causation:** Most non-communicable diseases follow this model (e.g., CAD is caused by smoking, obesity, and genetics). * **Endemic Goitre:** Defined when the prevalence of goitre in a population is >5%. The most common cause worldwide is iodine deficiency. * **Key takeaway:** Whenever you see a geographical or environmental factor linked to a nutritional deficiency disease, think **Indirect Association**.
Explanation: ### Explanation **Why "Effective Randomization" is Correct:** Randomization is the "heart" of a Randomized Controlled Trial (RCT). Its primary purpose is to **eliminate selection bias** and ensure that both the study and control groups are comparable in terms of both **known and unknown confounding factors**. By giving every participant an equal chance of being assigned to any group, it ensures that any observed difference in outcome is solely due to the intervention being tested. It is the "statistical gold standard" that transforms an observational study into a true experimental one. **Analysis of Incorrect Options:** * **A. Inclusion of all age groups:** This relates to the *generalizability* (external validity) of the study, not the internal validity or the core mechanism of the trial. Inclusion criteria depend on the specific research question. * **B. 50% treated with placebo and 50% with drugs:** While equal allocation is common, it is not mandatory. Trials can have unequal allocation (e.g., 2:1 ratio) for safety or ethical reasons without compromising the trial's validity. * **C. 100% follow-up:** While high follow-up is crucial to prevent "attrition bias," achieving 100% is practically impossible in large trials. The trial's integrity is maintained through "Intention-to-Treat (ITT) analysis" even if some participants are lost. **High-Yield Pearls for NEET-PG:** * **Randomization** eliminates **Confounding Bias**. * **Blinding** eliminates **Measurement/Observer Bias**. * **Allocation Concealment** (e.g., SNOSE - Sequentially Numbered Opaque Sealed Envelopes) is the method used to *implement* randomization and prevents selection bias before the intervention begins. * **RCT** is the best study design to establish **Causality**.
Explanation: **Explanation:** The **Framingham Heart Study** is the correct answer as it is the most iconic and influential large-sample prospective cohort study in the history of epidemiology. 1. **Why Framingham Study is correct:** Started in 1948 in Framingham, Massachusetts, this study initially recruited over 5,000 adults to identify the common factors or characteristics that contribute to **Coronary Heart Disease (CHD)**. It is responsible for coining the term **"risk factors"** and established the link between CHD and cigarette smoking, high blood pressure, high cholesterol, and physical inactivity. It is now in its third generation of participants. 2. **Why other options are incorrect:** * **North Karelia Study:** This was a community-based **intervention** study (not just observational) in Finland aimed at reducing high rates of CHD through lifestyle changes (dietary fat reduction). * **Stanford Study:** Known as the "Stanford Three-Community Study," it was a quasi-experimental study focused on **health education** and communication strategies to reduce cardiovascular risk. * **Oxford Study:** While there are many Oxford studies (e.g., the Oxford Family Planning Association Study), none are as synonymous with the foundational epidemiology of CHD risk factors as Framingham. **High-Yield Clinical Pearls for NEET-PG:** * **Study Design:** Framingham is the classic example of a **Prospective Cohort Study**. * **Key Finding:** It led to the development of the **Framingham Risk Score**, used to predict a patient's 10-year risk of developing cardiovascular disease. * **Incidence:** Cohort studies like Framingham are the best way to determine the **incidence** of a disease. * **Association:** It established that the risk of CHD increases with the number of risk factors present (synergistic effect).
Explanation: In epidemiology and demography, the term **Family Size** has a specific technical definition that differs from its common colloquial usage. ### 1. Why Option D is Correct In the context of public health and fertility studies, **Family Size** refers to the **total number of children a woman has given birth to at a specific point in time**. This is a measure of "completed fertility" if the woman has reached the end of her reproductive years, or "current fertility" if she is still in the reproductive age group (15–49 years). It focuses specifically on the reproductive output of the individual woman to calculate birth rates and population growth trends. ### 2. Analysis of Incorrect Options * **Option A:** This describes a **Household** or the sociological definition of a family unit. In epidemiology, "family size" is a fertility indicator, not a count of all cohabiting relatives (like grandparents or cousins). * **Option B & C:** These options describe the **Gross Reproduction Rate (GRR)** or Net Reproduction Rate (NRR) concepts, which specifically track female offspring to determine if a generation can replace itself. Family size includes children of both sexes. ### 3. Clinical Pearls & High-Yield Facts for NEET-PG * **Completed Family Size:** The number of children born to a woman who has completed her reproductive life (usually age 45 or 49). * **Total Fertility Rate (TFR):** The average number of children that would be born to a woman if she were to live to the end of her childbearing years. * **Replacement Level Fertility:** A TFR of **2.1** is considered the replacement level where a population exactly replaces itself from one generation to the next. * **Ideal Family Size:** In India, the current policy focus is on the "Small Family Norm" (often represented by the "Two-Child Norm").
Explanation: ### Explanation **Correct Answer: A. Disability-Adjusted Life Year (DALY)** The **Disability-Adjusted Life Year (DALY)** is the gold standard metric for measuring the **Global Burden of Disease (GBD)**. Unlike traditional mortality indicators, DALY is a composite measure that captures both the quantity and quality of life. It is calculated as the sum of: 1. **YLL (Years of Life Lost):** Due to premature mortality. 2. **YLD (Years Lived with Disability):** Due to the prevalence of disease/injury. **Logic:** One DALY represents the loss of one year of "healthy" life. It allows policymakers to compare the impact of a fatal disease (like Rabies) with a chronic, non-fatal disabling condition (like Depression) on a single scale. **Why other options are incorrect:** * **B. Sullivan’s Index:** Also known as "Disability-Free Life Expectancy." It calculates the expectation of life free of disability. While it measures health expectancy, it is not the standard metric for quantifying the total "burden" of specific diseases. * **C. Infant Mortality Rate (IMR):** This is a sensitive indicator of socio-economic development and healthcare availability, but it only reflects mortality in a specific age group (under 1 year) and ignores morbidity. * **D. Survival Index:** This measures the probability of survival (often used in cancer prognosis). It does not account for the quality of life or the burden of non-fatal illnesses. **High-Yield Clinical Pearls for NEET-PG:** * **DALY = YLL + YLD.** * **HALE (Health-Adjusted Life Expectancy):** The number of years a person is expected to live in "full health." * **PQLI (Physical Quality of Life Index):** Includes Literacy, IMR, and Life Expectancy at Age 1 (Scale 0-100). * **HDI (Human Development Index):** Includes Knowledge (Mean/Expected years of schooling), Income (GNI per capita), and Longevity (Life expectancy at birth).
Explanation: **Explanation:** The correct answer is **Prostate**. According to global epidemiological data (GLOBOCAN), prostate cancer is the most common cancer by incidence among males worldwide. **1. Why Prostate is Correct:** Prostate cancer has the highest incidence rate in men globally, largely due to increased life expectancy and the widespread use of Prostate-Specific Antigen (PSA) screening in developed nations. While its mortality rate is lower compared to lung cancer, the sheer number of new cases diagnosed annually makes it the leading malignancy by incidence. **2. Why the Other Options are Incorrect:** * **Lung Cancer:** While lung cancer is the **leading cause of cancer-related mortality** (death) in men globally, it ranks second to prostate cancer in terms of incidence. * **Colon Cancer:** Colorectal cancer is the third most common cancer in men. Its incidence is rising due to sedentary lifestyles and dietary changes but remains lower than prostate and lung cancers. * **Oropharynx:** While head and neck cancers (including oropharynx) are highly prevalent in specific regions like India due to tobacco and betel nut use, they do not surpass the global incidence of prostate cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Global (Males):** Most common incidence = **Prostate**; Most common mortality = **Lung**. * **Global (Females):** Most common incidence and mortality = **Breast**. * **India (Males):** Most common incidence = **Lip/Oral Cavity** (due to tobacco); Most common mortality = **Lung**. * **India (Females):** Most common incidence = **Breast** (Note: Cervical cancer was previously #1 but has been overtaken by breast cancer in most Indian registries). * **Overall (Global):** Breast cancer has now overtaken lung cancer as the most commonly diagnosed cancer worldwide (both sexes combined).
Explanation: ### Explanation The National Tuberculosis Programme (NTP), launched in 1962, faced significant challenges including low treatment completion rates and rising drug resistance. Following a joint review by the Government of India, WHO, and SIDA in 1992, the **Revised National Tuberculosis Control Programme (RNTCP)** was conceptualized and pilot-tested. **Why Option C is Correct:** The shift from NTP to RNTCP introduced the **DOTS (Directly Observed Treatment, Short-course)** strategy. A fundamental pillar of RNTCP was the systematic management of treatment failures and the eventual inclusion of a **strategy for multidrug-resistant TB (MDR-TB)** cases (Programmatic Management of Drug-Resistant TB - PMDT). Unlike the NTP, which relied on self-administered long-term regimens leading to high default rates and acquired resistance, RNTCP focused on standardized regimens and strict supervision to prevent and manage resistance. **Analysis of Incorrect Options:** * **A. Active case finding:** RNTCP primarily relies on **Passive Case Finding** (symptomatic patients reporting to health facilities). Active case finding is generally reserved for specific high-risk groups or elimination phases. * **B. Prophylactic vaccines:** BCG vaccination has been part of the Universal Immunization Programme (UIP) since before RNTCP; it was not a "new" differentiating feature of the 1992 revision. * **C. Unsupervised therapy:** This is the opposite of RNTCP’s core philosophy. RNTCP replaced unsupervised therapy with **Directly Observed Treatment (DOT)** to ensure adherence. **High-Yield Clinical Pearls for NEET-PG:** * **RNTCP Launch:** Pilot phase in 1993; National scale-up in 1997. * **Renaming:** In 2020, RNTCP was renamed the **National Tuberculosis Elimination Program (NTEP)**. * **Goal:** To achieve the Sustainable Development Goal (SDG) of ending TB by **2025** in India (5 years ahead of the global target of 2030). * **Diagnosis:** The current "Gold Standard" under NTEP for diagnosis is **CBNAAT/NAAT**, moving away from the traditional sputum microscopy used in early RNTCP.
Explanation: ### Explanation **Correct Answer: C. Cohort Study** **Why it is correct:** Temporal association (temporality) is the ability to establish that the exposure occurred *before* the outcome. A **Cohort study** is the gold standard for establishing temporality because it begins with a group of disease-free individuals and follows them forward in time (prospective) to see who develops the disease. Since the exposure is measured at the baseline when the subjects are healthy, we can definitively prove that the cause preceded the effect. This is a key criterion in **Bradford Hill’s Criteria of Causation**. **Why other options are incorrect:** * **A. Case-Control study:** These studies start with the "effect" (disease) and look backward to find the "cause" (exposure). Because they are retrospective, it is often difficult to prove whether the exposure truly preceded the disease or resulted from it (reverse causality). * **B. Cross-sectional study:** These are "snapshot" studies where exposure and outcome are measured simultaneously. This creates a "chicken or egg" dilemma, making it impossible to determine the temporal sequence. * **D. Descriptive study:** These studies (like Case Reports or Case Series) only describe the frequency and distribution of disease (Who, Where, When). They are used for hypothesis generation, not for testing associations or temporality. **High-Yield Clinical Pearls for NEET-PG:** * **Incidence:** Cohort studies are the only study type that can directly calculate the *Incidence* of a disease. * **Risk Measurement:** The primary measure of association in a Cohort study is **Relative Risk (RR)**, whereas in Case-Control, it is the **Odds Ratio (OR)**. * **Rare Exposures:** Cohort studies are best for rare exposures (e.g., a specific chemical leak), while Case-Control studies are best for rare diseases (e.g., rare cancers). * **Sequence of Strength:** In terms of evidence hierarchy: Meta-analysis > Systematic Review > RCT > Cohort > Case-Control > Cross-sectional.
Explanation: **Explanation:** The correct answer is **D (Less prone to bias)** because case-control studies are, in fact, **highly prone to bias**, particularly **Recall Bias** and **Selection Bias**. Since these studies are retrospective (looking backward from effect to cause), they rely heavily on the memory of participants or past medical records, which may be incomplete or inaccurate. **Analysis of Options:** * **A. Rapid and inexpensive:** This is true. Unlike cohort studies, case-control studies do not require long-term follow-up. They use existing data or interviews, making them the quickest and cheapest observational study design. * **B. No risk to subjects:** This is true. Because the investigator does not intervene or administer any drug/exposure (it is purely observational) and the outcome has already occurred, there is no physical risk to the participants. * **C. Risk factor can be identified:** This is true. Case-control studies are ideal for generating hypotheses and identifying potential risk factors (associations) for a disease, especially rare diseases. **Clinical Pearls for NEET-PG:** * **Measure of Association:** The Odds Ratio (OR) is the key statistic used in case-control studies. * **Rare Diseases:** Case-control studies are the **study of choice** for rare diseases (e.g., specific cancers). * **Nesting:** A "Nested Case-Control Study" is one conducted within a large cohort study, which helps reduce selection and information bias. * **Direction:** The direction of inquiry is **Backward** (Effect $\rightarrow$ Cause).
Explanation: **Explanation:** Cholera, caused by *Vibrio cholerae*, is the classic example of a **non-invasive, secretory diarrhea**. The primary pathology is mediated by the **cholera toxin (choleragen)**, which activates adenylate cyclase, leading to increased cAMP levels and the massive efflux of water and electrolytes into the intestinal lumen. 1. **Why Option A is correct:** While cholera is famously described as "painless" in many textbooks to differentiate it from dysentery, significant **abdominal cramping/pain** is frequently present due to the rapid distension of the bowel loops by massive fluid secretion. Furthermore, despite being a non-invasive infection, the profound dehydration and hemoconcentration (loss of plasma volume) lead to a "stress response" in the bone marrow, resulting in **peripheral neutrophilia**. 2. **Why other options are incorrect:** * **Fever (Options B & C):** *V. cholerae* does not invade the intestinal mucosa. Therefore, systemic inflammatory markers like fever are typically absent. The presence of fever should prompt a search for invasive pathogens like *Salmonella* or *Shigella*. * **Leukocytes in stool (Options B & D):** Since there is no mucosal invasion or ulceration, the stool in cholera is characteristically "rice-water" in appearance—clear fluid with flecks of mucus. It is **devoid of inflammatory cells (fecal leukocytes)** and blood. **High-Yield Clinical Pearls for NEET-PG:** * **Stool Characteristics:** Rice-water stool with a "fishy odor." * **Gold Standard Diagnosis:** Stool culture on **TCBS (Thiosulfate Citrate Bile Salts Sucrose) agar**, where it forms yellow colonies. * **Transport Media:** Venkatraman-Ramakrishnan (VR) medium or Cary-Blair medium. * **Treatment Priority:** Aggressive rehydration is the mainstay. Doxycycline is the drug of choice (DOC) to reduce the duration of shedding, though resistance is increasing.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free